AC Immune (ACIU) Other Operating Expenses (2014 - 2026)

For the trailing twelve months through Jun 30, 2026, Other Operating Expenses at AC Immune was $226,845, up 221.2% year-over-year; for the year ended Dec 31, 2025, it was $113,376, down 29.8% from the prior year.

• Annual Other Operating Expenses shows a five-year compound annual growth rate of -39.9% (years ended Dec 2020 to Dec 2025).
• In prior years, AC Immune's Other Operating Expenses was $161,412 in the year ended Dec 31, 2024 (-90.2%), $1.65 million in the year ended Dec 31, 2023 (+17.5%), $1.41 million in the year ended Dec 31, 2022 (+8.8%) and $1.29 million in the year ended Dec 31, 2021 (-10.3%).
• The figure for the quarter ended Jun 30, 2026 stands as the highest quarterly Other Operating Expenses since the quarter ended Dec 31, 2023.
• On a year-over-year basis, Other Operating Expenses increased in two of the last five quarters, with growth averaging 102.8%.
• The strongest year-over-year quarter for Other Operating Expenses in the past five years was the quarter ended Dec 31, 2025, with growth of 471.5%; the weakest was the quarter ended Dec 31, 2024, with a decline of 96.0%.